Home >
Medicine Info >
Evalon Forte Tablet
Loading interface...

Evalon Forte Tablet

Manufactured byMSD PHARMACEUTICALS PVT LTD
ContainsEstriol
Description
Evalon Forte Tablet is used for the treatment of problems arising due to diminished estrogen production after menopause (usually around the age of 50) and after surgical removal of the ovary.
QUICK LINKS:
Side effectsConcernsUsageRelated products

Side effects

Major & minor side effects for Evalon Forte Tablet

  • Headache
  • Skin rash
  • Breast enlargement
  • Feeling very tired or weak
  • Vaginal discharge
  • Nausea and vomiting

Uses of Evalon Forte Tablet

What is it prescribed for?

  • Postmenopausal symptoms
  • After ovarian surgery
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The amount of time required for this medicine to show its action is not clinically established.
  • How long do the effects of this medicine last?
    The amount of time for which this medicine remains active in the body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit-forming tendencies were reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women.

Allergy

This medicine is not recommended for use in patients who have a known allergy to estriol, any estrogen products or any other ingredient present along with the formulation.

Breast cancer

This medicine is not recommended for use in patients having breast cancer. It should also not be used if a patient has had breast cancer before or is suspected of having it.

Estrogen-dependent tumor

This medicine is not recommended for use in patients having cancer which is attributed to abnormal levels of the hormone estrogen in the body for a prolonged duration.

Liver disease

This medicine is not recommended for use in patients with liver diseases due to the increased risk of worsening of the patient's condition.

Unexplained vaginal bleeding

This medicine is not recommended for use if you have an abnormal episode of vaginal bleeding which was not diagnosed.

Heart and blood vessel disorder

This medicine is not recommended for use in patients having a disease of the heart or blood vessels viz. deep vein thrombosis, recent heart attack, other blood clotting disorders, etc.

Endometrial hyperplasia

This medicine is not recommended for use in patients with endometrial hyperplasia (a condition of excessive thickening of the womb lining) due to the increased risk of worsening of the patient's condition.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women.

Breast-feeding

This medicine is not recommended for use in breastfeeding women.
General warnings

Asthma

This medicine should be used with caution in patients with asthma due to the increased risk of worsening of the patient's condition. Appropriate dose adjustments or replacement with a suitable alternative may be necessary in some cases based on the clinical condition.

Diabetes

This medicine should be used with caution in patients with diabetes (increased blood sugar levels) due to the increased risk of worsening of the patient's condition. Close monitoring of blood sugar levels, appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be necessary in some cases based on the clinical condition.

Cardiovascular risks

This medicine has been associated with an increased risk of stroke, heart attack, and other complications associated with the heart. It should be used with caution in patients having heart disease or are exposed to the risk factors.

Jaundice like symptoms

This medicine may cause yellowing of the eyes and skin due to its effect on the liver and the gall-bladder. Report the presence of any symptom indicative of jaundice to the doctor on priority. The use of this medicine should be stopped in such cases.

Gall bladder disease

The use of this medicine can increase the risk of gallbladder diseases, especially in postmenopausal women. It should be used with caution in patients suffering from a disease of the gall bladder. Appropriate dose adjustments or replacement with a suitable alternative may be necessary in some cases based on the clinical condition.

Missed Dose

Take the missed dose as soon as you remember. If it is almost time for the next scheduled dose then the missed dose can be skipped.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Corticosteroids

Griseofulvin

Nevirapine

Carbamazepine

Disease interactions

Disease

Information not available.
Food interactions
Information not available.
Lab interactions
Information not available.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.
Take this medicine exactly as instructed by the doctor. Do not take this medicine in larger or smaller quantities or for longer durations than recommended. It is advised to do a regular follow-up with the doctor while taking this medicine.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

Effect on sleep is not established

How it works
This medicine works by replacing or replenishing the hormone estrogen that is normally produced in the body.
Legal Status

Approved

Unknown

Approved

Unknown

Classification

Category

Estrogens

Schedule

Schedule H

Estriol - DrugBank [Internet]. Drugbank.ca. 2019 [cited 2 January 2019]. Available from:

https://www.drugbank.ca/drugs/DB04573

Estriol [Internet]. Pubchem.ncbi.nlm.nih.gov. 2019 [cited 2 January 2019]. Available from:

https://pubchem.ncbi.nlm.nih.gov/compound/estriol

[Internet]. Nps.org.au. 2020 [cited 10 February 2020]. Available from:

https://www.nps.org.au/assets/medicines/10577a4c-7a6c-4ca6-b3f2-a53300fec09d-reduced.pdf
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 5 Mar 2020

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.